(Q48766624)

English

Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]). (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic headache

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

author name string

Paul J Spira

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

31

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

530-536

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

Evaluation of chronic daily headache--comparison to criteria for chronic tension-type headache.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Transformed or evolutive migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

The International Headache Society (IHS) headache classification as applied to a headache clinic population.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Determination of levetiracetam in human plasma with minimal sample pretreatment

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Clinical pharmacokinetics of levetiracetam

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Levetiracetam reduces anesthetic-induced hyperalgesia in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Valproic acid treatment of chronic daily headache

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Anticonvulsant drugs in primary headaches prophylaxis

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Prophylactic migraine therapy: emerging treatment options

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Efficacy and safety of levetiracetam in pediatric migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

An open-label pilot study on theefficacy and tolerability of levetiracetam in the prophylaxis of migraine.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

The importance of placebo in headache research

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Lessons from placebo effects in migraine treatment

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Placebo adverse events in headache trials: headache as an adverse event of placebo

1 reference

https://api.crossref.org/works/10.1177%2F0333102410384886

21 January 2018

Identifiers

10.1177/0333102410384886

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/21059626

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48766624&oldid=1984205055"